Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP7 | P09237 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | ECE1 | P42892 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | APLNR | P35414 | 2/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL778401 | 0.97 | MMP1 (0.35) | MMP1MMP7MMP12ECE1MMP13 | |
| SCHEMBL14966497 | 0.94 | — | — | |
| SCHEMBL2051129 | 0.88 | — | — | |
| SCHEMBL8134289 | 0.81 | MMP1 (0.33) | MMP1MMP7MMP12ECE1MMP13 | |
| SCHEMBL4814240 | 0.78 | MMP1 (0.32) | MMP1MMP7MMP12ECE1MMP13 | |
| SCHEMBL20714713 | 0.78 | MMP1 (0.38) | MMP1MMP7MMP12ECE1MMP13 | |
| SCHEMBL1060897 | 0.77 | CA1 (0.36) | CA12CA1CA7CA14SHBG | |
| SCHEMBL28838041 | 0.77 | — | — | |
| SCHEMBL2101635 | 0.76 | — | — | |
| SCHEMBL13162564 | 0.76 | GABRA1 (0.52) | EPHX1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11211671-B2 | Porous film, separator including the same, electrochemical device including separator, and method of preparing porous film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-12-28 | — | — | US | claimed |
| US-20190237731-A1 | POROUS FILM, SEPARATOR INCLUDING POROUS FILM, ELECTROCHEMICAL DEVICE INCLUDING POROUS FILM, AND METHOD OF PREPARING POROUS FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-08-01 | — | — | US | claimed |
| US-20190221809-A1 | POROUS FILM, SEPARATOR INCLUDING THE SAME, ELECTROCHEMICAL DEVICE INCLUDING SEPARATOR, AND METHOD OF PREPARING POROUS FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-18 | — | — | US | claimed |
| US-20190109309-A1 | POROUS FILM, SEPARATOR INCLUDING POROUS FILM, ELECTROCHEMICAL DEVICE INCLUDING POROUS FILM, AND METHOD OF PREPARING POROUS FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-04-11 | — | — | US | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-11942593-B2 | Lithium battery | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-03-26 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220102750-A1 | LITHIUM BATTERY | GWON HYEOKJO (KR) | 2022-03-31 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| US-11245130-B2 | Lithium battery | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-02-08 | — | — | US | disclosed |
| US-11211671-B2 | Porous film, separator including the same, electrochemical device including separator, and method of preparing porous film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-12-28 | — | — | US | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| CN-101432923-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP | 2012-04-18 | — | — | CN | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20110206783-A1 | P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | MERCK SHARP & DOHME LLC | 2011-08-25 | — | — | US | disclosed |
| CN-102097654-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP | 2011-06-15 | — | — | CN | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| CN-101432923-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP (JP) | 2009-05-13 | — | — | CN | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110206783-A1 | P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN | P2RX3, P2RX1, P2RX2 | MMP1 2206/4885MMP7 3968/4885MMP12 1196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.